Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -283,000 | -307,000 | -267,000 | 53,000 | -123,000 |
| Depreciation Amortization | -15,000 | -11,000 | 6,000 | 9,000 | 3,000 |
| Accounts receivable | 28,000 | 15,000 | 704,000 | -17,000 | -1,000 |
| Accounts payable and accrued liabilities | 3,000 | -1,000 | 8,000 | -5,000 | 9,000 |
| Other Working Capital | 22,000 | -71,000 | 623,000 | -376,000 | 208,000 |
| Other Operating Activity | 75,000 | 69,000 | -636,000 | 80,000 | 15,000 |
| Operating Cash Flow | $-170,000 | $-306,000 | $438,000 | $-256,000 | $111,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -114,000 | 194,000 | -547,000 | -29,000 | -431,000 |
| PPE Investments | -6,000 | -24,000 | -6,000 | -26,000 | -3,000 |
| Sale Of Investment | 36,000 | 24,000 | 143,000 | 51,000 | N/A |
| Other Investing Activity | 0 | 0 | -3,000 | 0 | 0 |
| Investing Cash Flow | $-84,000 | $194,000 | $-413,000 | $-4,000 | $-434,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 237,000 | 33,000 | 23,000 | 232,000 | 439,000 |
| Other Financing Activity | 40,000 | 0 | 10,000 | 5,000 | 0 |
| Financing Cash Flow | $277,000 | $33,000 | $33,000 | $237,000 | $439,000 |
| Beginning Cash Position | 130,000 | 209,000 | 151,000 | 174,000 | 58,000 |
| End Cash Position | 153,000 | 130,000 | 209,000 | 151,000 | 174,000 |
| Net Cash Flow | $23,000 | $-79,000 | $58,000 | $-23,000 | $116,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -170,000 | -306,000 | 438,000 | -256,000 | 111,000 |
| Capital Expenditure | -6,000 | -24,000 | -6,000 | -26,000 | -3,000 |
| Free Cash Flow | -176,000 | -330,000 | 432,000 | -282,000 | 108,000 |